Effective publication:
Huang Y, Hu W, Huang S, Chu J, Liang Y, Tao Z, Wang G, Zhuang J, Zhang Z, Zhou X, et al. Taxonomy and anticancer potential of Streptomyces niphimycinicus sp. nov. against nasopharyngeal carcinoma cells. Appl Microbiol Biotechnol 2023; 107:6325-6338. 🇨🇳
IJSEM list:
Oren A, Göker M. Validation list no. 228. List of new names and new combinations previously effectively, but not validly, published. Int J Syst Evol Microbiol 2026; 76:7052.
Nomenclatural status:
validly published under the ICNP
Taxonomic status:
correct name (and explicitly recommended for medical use)
Notes:
😢 The terminology used by the authors is in line with many other taxonomic studies and does not negatively affect their main results; some improvements may nevertheless be possible. Using the term "phylogenetic data" (or equivalent) for sequence data is not advocated. Whether taxa can have "members" is debatable. See the LPSN phylogeny page for details.Publication:
Göker M. What can genome analysis offer for bacteria? In: Bridge P, Smith D, Stackebrandt E (eds), Trends in the systematics of bacteria and fungi, CAB International, Wallingford, 2021, p. 255-281. 🇬🇧
🎓 Name mentioned 1 time in PubMed until 2026-06-11.
🙆 This name is on the List of Recommended Names for bacteria of medical importance (LoRN) as the name to be applied to this species. The name is on LoRN because of the recorded risk group of the genus.
Assigned by:
Huang Y, Hu W, Huang S, Chu J, Liang Y, Tao Z, Wang G, Zhuang J, Zhang Z, Zhou X, et al. Taxonomy and anticancer potential of Streptomyces niphimycinicus sp. nov. against nasopharyngeal carcinoma cells. Appl Microbiol Biotechnol 2023; 107:6325-6338. 🇨🇳
Linking:
To permanently link to this page, use https://doi.org/10.83108/rn.39891Link copied to clipboard
Record number:
39891
Previous versions:
Version
Date
JSON
1
2026-03-31
×
Support LPSN
Please sign and share this petition calling for caution before changing bacterial names in databases.